Matches in SemOpenAlex for { <https://semopenalex.org/work/W2972701333> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2972701333 endingPage "S246" @default.
- W2972701333 startingPage "S246" @default.
- W2972701333 abstract "Lung dosimetry is correlated with radiation pneumonitis (RP) in lymphoma patients treated with mediastinal intensity modulated radiation therapy (IMRT). Furthermore, salvage chemotherapy in the refractory setting and the inflammatory milieu may influence toxicity and outcomes. We hypothesized that implementation of strict dosimetric lung constraints (DLCs) would lower the RP rate compared to historical data. We also examined the relationship between pre-IMRT neutrophil-lymphocyte ratio (NLR) and symptomatic RP. We retrospectively reviewed 261 patients with mediastinal lymphoma treated with IMRT between 2009 and 2018; 190 and 71 patients were treated, respectively before and after implementation of DLCs- mean lung dose (MLD) ≤ 13.5 and total lung irradiated to > 5 Gy (V5) ≤ 55%. We compared symptomatic RP incidence before and after DLC implementation and analyzed the clinical, treatment, and dosimetric factors associated with RP. We compared pre-IMRT NLR in patients who did and did not develop RP. Overall, median age was 33 years, 54.4% were female and 82% had stage I/II lymphoma. Also, 75% of patients (n=195) received IMRT after frontline chemotherapy (median dose 30.6 Gy); 25% of patients (n=66) received IMRT after salvage chemotherapy for refractory disease (median dose 39.8 Gy). The RP incidence was lower in patients treated after DLC implementation (5/71) compared to those treated before (27/190) (7.0% vs 14.2%, p=0.12). In patients treated after DLC implementation, 97% (n=69) had MLD ≤ 13.5 Gy and 91% (n=64) had V5 ≤ 55 %. For patients who received IMRT after frontline chemotherapy, RP incidence was significantly lower after implementation of the DLCs (0/49) compared to those treated before (16/146) (0 vs 11%, p=0.02). While the lung V10, V15, V20, and V25 were significantly lower (p<0.05) for patients treated for refractory lymphoma after DLC implementation (n=22) compared to those treated before (n= 44), the incidence of RP was similar in refractory patients treated before (11/44, 25%) and after (5/22, 22.7%) DLC implementation (p>0.05). In the 66 patients who received prior salvage chemotherapy, mean pre-IMRT NLR was significantly lower in patients who developed RP than those who did not (2.04 vs 5.42, p = 0.02). After institutional implementation of MLD ≤ 13.5 Gy and V5 ≤ 55 %, RP incidence was reduced in patients receiving IMRT after frontline chemotherapy, with no patients experiencing RP. However, RP incidence was similar before and after employment of DLCs in patients treated with salvage chemotherapy prior to RT. Thus, stricter DLCs and inflammatory factors may influence RP risk in the salvage population despite lower lung doses after DLC implementation. NLR should be further evaluated as a potential factor associated with RP in lymphoma patients treated with IMRT for refractory disease." @default.
- W2972701333 created "2019-09-19" @default.
- W2972701333 creator A5007578449 @default.
- W2972701333 creator A5007688820 @default.
- W2972701333 creator A5009933533 @default.
- W2972701333 creator A5031498320 @default.
- W2972701333 creator A5036616928 @default.
- W2972701333 creator A5043635164 @default.
- W2972701333 creator A5059256779 @default.
- W2972701333 creator A5091294211 @default.
- W2972701333 date "2019-09-01" @default.
- W2972701333 modified "2023-10-18" @default.
- W2972701333 title "Dosimetric Lung Constraints and Neutrophil-Lymphocyte Ratio as Predictors of Radiation Pneumonitis in Lymphoma Patients treated with Mediastinal IMRT" @default.
- W2972701333 doi "https://doi.org/10.1016/j.ijrobp.2019.06.363" @default.
- W2972701333 hasPublicationYear "2019" @default.
- W2972701333 type Work @default.
- W2972701333 sameAs 2972701333 @default.
- W2972701333 citedByCount "0" @default.
- W2972701333 crossrefType "journal-article" @default.
- W2972701333 hasAuthorship W2972701333A5007578449 @default.
- W2972701333 hasAuthorship W2972701333A5007688820 @default.
- W2972701333 hasAuthorship W2972701333A5009933533 @default.
- W2972701333 hasAuthorship W2972701333A5031498320 @default.
- W2972701333 hasAuthorship W2972701333A5036616928 @default.
- W2972701333 hasAuthorship W2972701333A5043635164 @default.
- W2972701333 hasAuthorship W2972701333A5059256779 @default.
- W2972701333 hasAuthorship W2972701333A5091294211 @default.
- W2972701333 hasBestOaLocation W29727013331 @default.
- W2972701333 hasConcept C120665830 @default.
- W2972701333 hasConcept C121332964 @default.
- W2972701333 hasConcept C126322002 @default.
- W2972701333 hasConcept C126838900 @default.
- W2972701333 hasConcept C142424586 @default.
- W2972701333 hasConcept C2776694085 @default.
- W2972701333 hasConcept C2777714996 @default.
- W2972701333 hasConcept C2779338263 @default.
- W2972701333 hasConcept C2779524853 @default.
- W2972701333 hasConcept C2780775027 @default.
- W2972701333 hasConcept C2989005 @default.
- W2972701333 hasConcept C509974204 @default.
- W2972701333 hasConcept C61511704 @default.
- W2972701333 hasConcept C71924100 @default.
- W2972701333 hasConcept C87355193 @default.
- W2972701333 hasConceptScore W2972701333C120665830 @default.
- W2972701333 hasConceptScore W2972701333C121332964 @default.
- W2972701333 hasConceptScore W2972701333C126322002 @default.
- W2972701333 hasConceptScore W2972701333C126838900 @default.
- W2972701333 hasConceptScore W2972701333C142424586 @default.
- W2972701333 hasConceptScore W2972701333C2776694085 @default.
- W2972701333 hasConceptScore W2972701333C2777714996 @default.
- W2972701333 hasConceptScore W2972701333C2779338263 @default.
- W2972701333 hasConceptScore W2972701333C2779524853 @default.
- W2972701333 hasConceptScore W2972701333C2780775027 @default.
- W2972701333 hasConceptScore W2972701333C2989005 @default.
- W2972701333 hasConceptScore W2972701333C509974204 @default.
- W2972701333 hasConceptScore W2972701333C61511704 @default.
- W2972701333 hasConceptScore W2972701333C71924100 @default.
- W2972701333 hasConceptScore W2972701333C87355193 @default.
- W2972701333 hasIssue "1" @default.
- W2972701333 hasLocation W29727013331 @default.
- W2972701333 hasOpenAccess W2972701333 @default.
- W2972701333 hasPrimaryLocation W29727013331 @default.
- W2972701333 hasRelatedWork W1967003708 @default.
- W2972701333 hasRelatedWork W2040492280 @default.
- W2972701333 hasRelatedWork W2041235190 @default.
- W2972701333 hasRelatedWork W2048191209 @default.
- W2972701333 hasRelatedWork W2388889455 @default.
- W2972701333 hasRelatedWork W2391627076 @default.
- W2972701333 hasRelatedWork W2415576058 @default.
- W2972701333 hasRelatedWork W2416632858 @default.
- W2972701333 hasRelatedWork W2464045689 @default.
- W2972701333 hasRelatedWork W2467023771 @default.
- W2972701333 hasVolume "105" @default.
- W2972701333 isParatext "false" @default.
- W2972701333 isRetracted "false" @default.
- W2972701333 magId "2972701333" @default.
- W2972701333 workType "article" @default.